News Sentiment

SUPN sentiment intelligence

Supernus Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 46 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 48.46 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.9% over one week, +9.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Supernus marks five years since Qelbree ADHD drug approval By Investing.com

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction 0.9% Price digesting
Trend fit Trend inactive 9.1% over four weeks
Fair value 32.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 25
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 16
Market source 6
GlobeNewswire 5
GuruFocus 2
Sahm 2
StockStory 2
Investing.com South Africa 1
BBN Times 1

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 14
Analyst action 4
Deals and strategy 4
Regulatory and legal 2
Balance sheet 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-46 of 46